dallas tx 9/9/2009 12:41:29 AM
News / Business

ACCP, EWRC, GOHG, GSAE, CHYU, MRNJ, SNRY, OPXA, APNO, SOFN, SDSS OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, September 8th

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.

Our Stocks to Watch today include Access Pharmaceuticals Inc. (OTCBB: ACCP), eWorld Companies Inc. (OTC: EWRC), Alpha 1 Security/Global Holdings Inc. (OTCBB: GOHG), Green Star Alternative Energy Inc. (OTC: GSAE), China Youth Media Inc. (OTCBB: CHYU), Metatron Inc. (OTC: MRNJ), Solar Energy Initiatives Inc. (OTCBB: SNRY), Opexa Therapeutics Inc. (Nasdaq: OPXA), Alpha Innotech Corp. (OTCBB: APNO), SoftNet Technology Corp. (OTCBB: SOFN) and Suspect Detection Systems Inc. (OTCBB: SDSS).

 

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.

 

ACCESS PHARMACEUTICALS INCORPORATED (OTCBB: ACCP)

 

Detailed Quote: http://www.otcpicks.com/quotes/ACCP.php 

 

Company Profile: http://www.otcpicks.com/access-pharmaceuticals/access-pharmaceuticals.htm 

 

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac™, currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard™ for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin™-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix®, a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers.

 

ACCP News:

 

September 1 - Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference

 

Access to Provide Update on MuGard Global Commercial Launch and ProLindac Clinical Development Plans

 

Access Pharmaceuticals, Inc. (OTCBB: ACCP) announced that Access will present at the Rodman & Renshaw 11th Annual Healthcare Conference to be held September 9-11, 2009 at the New York Palace Hotel in New York City. Jeffrey B. Davis, President and CEO of Access is scheduled to speak on Friday, September 11, 2009 at 10:50 am EDT in the Fahnestock Salon (5th Floor) and will give a corporate overview and discuss the Company's product opportunities.

 

Visit www.wsw.com/webcast/rrshq15/accp.ob to view the presentation. A replay can be obtained at the same link for up to 90 days after the live presentation.

 

ABOUT MUGARD

 

MuGard is a novel, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 40% of all patients receiving chemotherapy and/or radiotherapy develop moderate to severe mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop mucositis. Updated clinical practice guidelines for the prevention and treatment of mucositis recommend the use of a preventive oral care regimen as part of routine supportive care along with a therapeutic oral care regimen if mucositis develops. The market for the treatment of oral mucositis, used prophylactically for patients undergoing chemotherapy and radiation therapy, is estimated to be in excess of $5 billion world-wide.

 

ABOUT PROLINDAC™

 

ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion. Access has previously announced that it has licensed ProLindac to Aosaikang Medicinal Group ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partners will be conducting Phase 2 combination studies with ProLindac in specific tumor types at their expense based on these results.

 

EWORLD COMPANIES INCORPORATED (OTC: EWRC)

 

Detailed Quote: http://www.otcpicks.com/quotes/EWRC.php 

 

Company Profile: http://www.otcpicks.com/eworld-companies/eworld-companies.htm 

 

eWorld Companies, Inc. is an online marketing & advertising technologies company that develops and markets cutting edge technologies using rich media, flash, animation and 3D graphics to help individuals and businesses market and advertise online. eWorld's revenue model consists of seven components: (1) Affiliation Fees, (2) Affiliate Monthly Subscriptions, (3) Affiliate Benefit Subscriptions, (4) Product Sales, (5) Advertising Revenues, (6) Web Development Accounts, and (7) International Licensing Fees.

 

EWRC News:

 

September 8 - eWorld Companies Reports Progress in Development of Boomerang Application for Mobile Phones

 

eWorld Companies, Inc. (OTC: EWRC) announced that work is proceeding more quickly than expected on a mobile application for its Boomerang Media Station™. According to eWorld CEO Henning Morales, eWorld's tech team has been working on a mobile application almost since the Boomerang concept was formed, and the final pieces of the technology are nearly in place to bring the project to fruition.

 

Mr. Morales commented, "We have successfully created a prototype simplified version of the Boomerang that is compatible with mobile applications and can be downloaded onto some mobile phones. Our next steps will be to improve the performance and robustness of the technology, enhance and modify it to work with a wider variety of mobile devices, and secure the necessary licensing agreements to bring it to market as soon as possible."

 

ALPHA 1 SECURITY INCORPORATED (OTCBB: GOHG)

"Up 5.00% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/GOHG.php 

 

Company Profile: http://www.otcpicks.com/global-holdings/global-holdings.htm

 

Alpha 1 provides Internet based (IP) data security services as well as develops and markets software and microprocessor-based products. Alpha1's primary data security products use an advanced form of computer security technology referred to as public key infrastructure (PKI) which enables Alpha1's products to integrate. Alpha1 is an approved NSA C-2 classified contractor.

 

GOHG News:

 

August 18 - Alpha1 Security Announces New $14 Million Submitted Bid to the Department of Defense

 

Alpha1 Security announces a bid valued at up to $14mm to the Department of Defense to provide secure wireless communications, services and hardware to each division within the Department. As previously announced Alpha1 Security Inc. has entered into an acquisition agreement with Global Holdings, Inc. (OTCBB: GOHG).

 

The services Alpha1 Security provides would be based on our patent-protected technology that Alpha1 Security owns. The technology revolutionizes the way in which enterprises connect wireless networks securely.

 

"Alpha1 Security is the technology leader of secure wireless networking technology -- our technology has been reviewed and endorsed by the government. We are the leader in security technology that has been reviewed and endorsed by the National Security Agency and is C2 certified," says Mark McCloy, COO and President, Alpha1 Security Inc.

 

Alpha1 Security is the technology leader in the $20BB market for providing secure network solutions and services. Alpha1 provides Internet based (IP) data security services as well as develops and markets software and microprocessor-based products. Alpha1's primary data security products use an advanced form of computer security technology referred to as public key infrastructure (PKI) which enables Alpha1's products to integrate. Alpha1 is an approved NSA C-2 classified contractor.

 

GREEN STAR ALTERNATIVE ENERGY INCORPORATED (OTC: GSAE)

 

Detailed Quote: www.otcpicks.com/quotes/GSAE.php 

 

Company Profile: http://www.otcpicks.com/Newsletter/GSAE_eProfile_091708.htm 

 

Green Star Alternative Energy is an environmentally conscious, renewable energy producer. The Company is working to develop more than 300 MW (megawatts) of clean electricity through wind energy. The corporate revenue model is two-fold: the use of a renewable resource allows not only for the creation of environmentally friendly energy, but the granting of carbon (greenhouse gas) emission credits which may be traded and sold. Green Star is pursuing a significant opportunity to provide clean energy to the growing Republic of Serbia and neighbouring European countries. Through a joint venture with key wind farm and power trading company Notos, Green Star will become the nation's first developer of wind power. GSAE is focussed on green technology and sustainable energy programs like wind turbines, hydro electric power generation, and other renewable electricity models.

 

GSAE News:

 

August 27 - A New Audio Interview with Mike Andric, CEO of Green Star Alternative Energy, Inc., is Now at SmallCapVoice.com

 

SmallCapVoice.com, Inc. announced that a new audio interview with Green Star Alternative Energy, Inc. (OTC: GSAE) is now available. The interview can be heard at http://smallcapvoice.com/blog/8-26-09-audio-interview-with-green-star-alternative-energy-inc-otcpk-gsae.

 

CHINA YOUTH MEDIA INCORPORATED (OTCBB: CHYU)

 

Detailed Quote: http://www.otcpicks.com/quotes/CHYU.php 

 

Company Profile: Coming Soon.

 

China Youth Media, Inc. is a China-focused youth marketing and media company whose business is to deliver advertising and content to one of the most sought after and fastest growing demographics in the world. Through its wholly owned subsidiary Youth Media (Hong Kong) Limited, CHYU has secured contracts with a term of 20 plus 10 years that provide exclusive rights from the Chinese government controlled corporation, China Youth Interactive, which uniquely position CHYU to market to China’s massive student population with preferred access online, on campus and on mobile. CHYU currently targets China’s campus-based college students, who total more than 30 million and make up a key segment of the largest youth market in the world.

 

CHYU News:

 

September 8 - China Youth Media to Present at Rodman & Renshaw Annual Global Investment Conference

 

China Youth Media, Inc. (OTCBB: CHYU), a China-focused youth marketing and media company, announced today that Jay Rifkin, Chief Executive Officer, will present at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel in New York, NY, on Wednesday, September 9, 2009 at 10:00 a.m. ET.

 

The Conference, featuring keynote speaker Dr. Alan Greenspan, has a strong Asia Track dedicated to China-focused companies. Mr. Rifkin will present an overview of China Youth Media and report the latest progress of its Intranet Television Network and media portal, Koobee, which is targeted to China’s 30 million plus college students. Mr. Rifkin will also discuss plans for the launch of China Youth Media’s eCommerce and mobile platforms in China.

 

“The Rodman Conference offers an excellent opportunity for China Youth Media to showcase its milestones and accomplishments to date within the investment community,” commented Mr. Rifkin. “We look forward to sharing the exciting news of our latest developments.” Mr. Rifkin is also scheduled to meet one-on-one with prospective investors, analysts and business partners.

 

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., will hold its Annual Global Investment Conference from September 9-11, 2009. More than 500 public and private companies from across the globe will present to an expected audience of more than 3,500 attendees, including institutional investors, venture capitalists, private equity firms, business executives and other experts on the Asian markets.

 

METATRON INCORPORATED (OTC: MRNJ)

"Up 15.74% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/MRNJ.php 

 

Metatron Inc. is a diversified internet holding company with a mission to harness the power of today's online and wireless consumer interactivity to make daily life easier, more productive and more entertaining for people all over the world. Our objective is to acquire high potential internet properties and to monetize those operations based on our extensive experience and knowledge of Web 2.0, the second generation of web development and design that facilitates nearly-universal communication, secure information sharing, interoperability, and collaboration on the web.

 

MRNJ News:

 

September 8 - Metatron, Inc. Closes Acquisition of Mobile Phone Software Developer i-Mobilize

 

Company Becomes Wholly Owned Subsidiary of Metatron, Inc.

 

Metatron, Inc. (OTC: MRNJ) announced that is has completed the acquisition of i-Mobilize, Inc. for 1500 shares of its restricted shares of its common stock valued at $ .35 per share. Metatron, Inc. will also assume costs for all current i-Mobilize software and the hundreds of titles currently under development.

 

i-Mobilize's mission is to be a leading global provider and developer of mobile applications for the iPhone, Palm's new Pre, BlackBerry, T-Mobile's G1 and other mobile devices. Strategy Analytics claims the mobile content market will reach $67 billion in 2009, up 18% from the previous year.

 

Metatron and i-Mobilize have operated under a joint venture agreement since July 28, 2009. During this time the combined companies have several popular mobile applications on sale now and over thirty more currently under review. Each of the apps released so far have made the top 50 in their respective categories with thousands of downloads daily, earning an average rating of four stars each.

 

Commenting on the acquisition, Joe Riehl, CEO of Metatron, stated, "I am please to welcome i-Mobilize to the Metatron umbrella of companies. With the surge of the mobile application market, we felt that i-Mobilize was the logical first choice. We are very excited to be teaming up with Apple iPhone for its mobile applications and our joint ability to reach multiple target markets and generate significant revenue over the next several months. This is the first of many targeted acquisitions which will be in keeping with Metatron's overall strategic monetization business model. "

 

ABOUT I-MOBILIZE INC.

 

i-Mobilize's mission is to be a leading global provider and developer of mobile applications for the iPhone, Palm's new Pre, BlackBerry, T-Mobile's G1 and other mobile devices. Strategy Analytics claims the mobile content market will reach $67 billion in 2009, up 18% from 2008.

 

SOLAR ENERGY INITIATIVES INCORPORATED (OTC BB: SNRY)

"Up 5.00% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SNRY.php 

 

Solar Energy Initiatives, Inc. (www.SolarEnergy.com) is executing its “RENEW THE NATION” campaign, intended to promote job growth nationwide via an aggressive grass roots effort. The main focus of RENEW THE NATION will be working with companies in the construction industry and related trades affected by the economic downturn to re-train and re-deploy their workforce, allowing this important national asset to meet the needs of the Solar Energy industry, the fastest growing industry in the world. We are executing on a three-pronged approach to achieve our plan. This includes: continuing development of one of the fastest growing dealer networks in the U.S. that sells and installs solar solutions to homeowners and commercial customers; placing solar systems on large commercial buildings and selling the energy output to the owner/occupant(s); and becoming a developer of solar parks bringing together landowners, utilities and our corporate resources to build large photovoltaic installations. The Company’s dealer network of solar energy installers has access to Suntech Power Holdings Co., Ltd. (NYSE: STP), BP Solar (NYSE: BP) and GE Solar (NYSE: GE) equipment via its distribution agreements. While Solar Energy Initiatives is not a solar franchise, and the Company does not compete directly with industry giants such as First Solar (Nasdaq: FSLR), Kyocera (NYSE: KYO) or Sanyo (OTC: SANYY), as a system integrator, it provides exciting and practical solutions to businesses and individuals worldwide that understand the value of solar power.

 

SNRY News:

 

September 8 - Solar Energy Initiatives, Inc. Partners with Jacksonville Job Programs to Train Displaced Workers for Solar Industry

 

Federal Stimulus Money Officially Kicks-Off RENEW THE NATION Campaign

 

Solar Energy Initiatives, Inc. (OTCBB: SNRY) announced a partnership with three Jacksonville job training and placement agencies to train displaced workers as solar energy installation and maintenance technicians.

 

This new partnership is a first step in Solar Energy’s Renew the Nation campaign intended to promote job growth and economic development nationwide by providing a trained workforce to enter the fast growing renewable energy industry. The program, pending final approval by the Jacksonville City Council, is being funded in part by $396,000 in federal stimulus dollars provided by the American Recovery and Reinvestment Act of 2009.

 

Joining Solar Energy in this job training collaborative is Community Rehabilitation Center (CRC), Northeast Community Action Agency (NFCAA) and WorkSource. Solar Energy is providing the training curriculum and materials, while CRC will manage the program and NFCAA and WorkSource will supply the trainees.

 

The training facility, to be called CRC Institute, will be located at Pearl Plaza at the corner of North Pearl and 44th streets. The first class is anticipated to begin in late October.

 

“CRC is proud to join forces with Solar Energy, WorkSource and NFCAA,” said Reginald Gaffney, CRC’s Executive Director and Chief Executive Officer. “This collaborative program will help train people who have lost their jobs due to the downturn in economy and prepare them for the new green economy.”

 

Added Solar Energy’s Chief Executive Officer, David Fann, “The rapidly growing solar market requires a knowledgeable workforce with expertise in both construction and installation practices. Through this partnership, we will be preparing trained and valued workers for the solar industry.”

 

Solar Energy’s business model focuses on three fronts:

 

* Solar Parks. Development of large utility-scale photovoltaic (PV) installations bringing together landowners, utilities and corporate resources to build and operate.

 

* Solar Power Purchase Agreements (SPPA). Placing solar systems on or adjacent to commercial or municipal buildings and selling the energy output to the owner(s).

 

* Solar Dealers. One of the fastest growing independent dealer networks that sells and installs solar systems to homeowners and commercial customers.

 

Last week Solar Energy announced Letters of Intent for $17 million in commercial Projects that will utilize approximately 20,000 solar panels producing up to 4 megawatts of solar electricity and projected to reduce hazardous carbon dioxide emissions by 6,000 tons, annually. Solar Energy also recently completed training its 78th solar dealer and signed a contract securing land for the development of a 300 megawatt solar park in west Texas.

 

The Company’s dealer network of solar energy installers has access to BP Solar (NYSE: BP) and GE Solar (NYSE: GE) and Suntech (NYSE: STP) via its distribution agreements. While Solar Energy Initiatives is not a solar franchise, and the company does not compete directly with industry giants such as First Solar (Nasdaq: FSLR), Kyocera (NYSE: KYO), or Sanyo (OTC: SANYY) as a system integrator, it provides exciting and practical solutions to businesses, governments, municipalities and individuals worldwide that understand the value of solar power.

 

OPEXA THERAPEUTICS INCORPORATED (NASDAQ: OPXA)

"Up 118.95% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/OPXA.php

 

Opexa Therapeutics, Inc. is dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases. The Company’s leading therapy, Tovaxin, is an individualized cellular immunotherapy treatment in Phase IIb clinical development for Multiple Sclerosis (MS). Tovaxin is derived from T-cells isolated from peripheral blood, expanded ex vivo, and reintroduced into the patients via subcutaneous injections. This process triggers a potent immune response against specific subsets of autoreactive T-cells known to attack myelin and, thereby, reduces the risk of relapse over time. Data from the first Phase IIb clinical study showed compelling evidence that Relapsing Remitting MS patients treated with Tovaxin saw overall clinical, MRI, and immunological benefits over the placebo group, including statistical significance for decrease in the Annualized Relapse Rate (ARR), improvement in disability score (EDSS), and improvement in quality of life measures (MSQLI), as well as an excellent safety profile with no serious adverse events related to Tovaxin treatment.

 

OPXA News:

 

September 8 - Opexa to Present at the Rodman & Renshaw 11th Annual Healthcare Conference September 11, 2009

 

Opexa Therapeutics, Inc. (Nasdaq: OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), announced that Neil K. Warma, Opexa’s president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw’s 11th Annual Healthcare Conference. The conference will be held September 9-11, 2009, at the Palace Hotel in New York City.

 

Opexa’s presentation will take place at 10:50 a.m. (EST) on Friday, September 11, 2009 in the Henry Salon (5th floor) of the NY Palace Hotel. The presentation will include an overview of the company’s ongoing development program for Tovaxin, the company’s lead therapy for MS and an overview of the recently announced stem cell agreement with Novartis.

 

ALPHA INNOTECH CORPORATION (OTCBB: APNO)

"Up 67.05% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/APNO.php

 

With over 10,000 systems sold worldwide, Alpha Innotech is a leading developer, manufacturer, and marketer of digital imaging and analysis systems for the life science research and drug discovery markets. Its goal is to combine instruments, reagents and bioinformatics software in order to offer integrated modular technology platforms for functional genomics, proteomics, and cell analysis markets. Customers of Alpha Innotech include pharmaceutical and biotechnology companies, as well as universities, medical centers, government research institutes, and agencies worldwide.

 

APNO News:

 

September 8 - Cell Biosciences Signs Agreement to Acquire Alpha Innotech

 

Cell Biosciences, Inc. and Alpha Innotech Corp. (OTCBB: APNO) announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per share, or approximately $17.9 million in cash. This acquisition would significantly expand Cell Biosciences’ protein analysis business to include a global infrastructure and a broad protein analysis product portfolio.

 

Founded in 1992, Alpha Innotech is a pioneer in the use of high-sensitivity digital imaging systems for genomic and proteomic research. The company offers a broad range of best-in-class products, from entry-level gel documentation systems to premier systems for multiplexed fluorescence and proteomics applications. The company has sold over 10,000 systems worldwide. In 2008, Alpha Innotech achieved revenues of $17.6 million and was profitable on both an operating and a net income basis. Alpha Innotech employs 62 people, primarily at its San Leandro, California headquarters.

 

Cell Biosciences is a private life sciences company established in 2004, and is focused on revolutionizing protein and biomarker research. The company’s lead product is the CB1000, a nanofluidic immunoassay platform designed for ultrasensitive detection and characterization of oncoproteins and other signaling proteins in ultra‐small biological samples, such as small tumor biopsies and stem cells. Cell Biosciences is headquartered in Santa Clara, California, and has 49 employees located in North America and Europe.

 

The combination of Cell Biosciences and Alpha Innotech would create a global protein analysis business with a broad product line featuring both traditional and novel protein analysis technologies. Virtually every protein research laboratory worldwide would become a potential customer for the combined entity.

 

Commenting on the transaction, Tim Harkness, President and Chief Executive Officer of Cell Biosciences, said, “This strategic acquisition marks an important milestone in our plan to create a profitable, high-growth protein analysis business with global reach. There is a great strategic fit in people, products, technologies, and customers between Cell Biosciences and Alpha Innotech. I am particularly excited by the critical mass of talent and industry experience this combination creates.”

 

Ron Bissinger, Chief Executive Officer at Alpha Innotech, added, “The innovative technology of Cell Biosciences makes it an ideal partner for Alpha Innotech. I expect the combined company to create great value for our customers and employees, and to generate exceptional products for the protein research community.”

 

Under the terms of the agreement, Cell Biosciences will acquire Alpha Innotech for approximately $17.9 million, or $1.50 per share, and will assume $2.1 million of outstanding debt, net of cash. The completion of the transaction is subject to customary terms and conditions, including approval by the stockholders of Alpha Innotech. The directors, executive officers and certain stockholders of Alpha Innotech, who collectively hold approximately 33% of Alpha Innotech's outstanding common stock, have entered into agreements with Cell Biosciences pursuant to which they have agreed to vote their shares of Alpha Innotech common stock in favor of the transaction. The parties expect the transaction to be completed in approximately 60 days.

 

In connection with the transaction, Cell Biosciences has entered into agreements to raise an additional $19 million in cash in a second closing of a Series C Preferred Stock financing and a Series D Preferred Stock financing led by its largest investor, The Wellcome Trust. Existing investors Domain Associates, Novo A/S, Latterell Venture Partners, The Vertical Group and Royal Bank of Canada have agreed to participate in the financing.

 

BroadOak Partners served as financial advisor to Alpha Innotech in connection with the transaction.

 

ABOUT CELL BIOSCIENCES

 

Cell Biosciences is a private life sciences company focused on nanoproteomics. The Company develops instrumentation systems, software, and assay products that reveal previously undetectable information about cellular control pathways. Its customers include leading institutions in the fields of cancer research, stem cell biology, and diabetes. Cell Biosciences’ products enable researchers to uncover fundamental mechanisms controlling cell proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Biosciences is located in Santa Clara, California.

 

SOFTNET TECHNOLOGY CORPORATION (OTCBB: SOFN)

"Up 162.50% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SOFN.php

 

SoftNet Technology Corp. is a Professional Services company offering professional expertise to enterprise and service provider clients. SoftNet's services are organized in three practice specialties, including Infrastructure Services, Application Development and Government Services.

 

SOFN News:

 

January 21 - SoftNet Technology Selected as Preferred Provider by National Telco

 

SoftNet Technology Corp. (OTCBB: SOFN) (German WKN: TG6) announced that it has been selected as a Preferred Provider for a National Wireless Telecommunications provider.

 

SoftNet management participated in a rigorous RFP process by the company of which the pool of providers was limited to approximately one in four of the organizations seeking status of Preferred Provider by this carrier. The reduction in the number of authorized providers will add value to our relationship with the client and the Company's overall business plan. Prior to the RFP, SoftNet was competing with numerous like firms. With the selection of fewer firms in the RFP process SoftNet will be one of a few select companies submitting against numerous projects and engagements this client relies on from outside Professional Services firms. The selection of SoftNet was based on a number of factors, including the Company's long term standing with the carrier, the reputation for supplying quality candidates for engagements, the competitive pricing structure SoftNet is able to achieve and the attention to the account by SoftNet Management.

 

“The management team of SoftNet is proud of this selection. It speaks to the focus the Company places on client satisfaction, the quality of work performed and the relationship of managers with their peers at a customer organization. The benefit of this status is that it could result in an increase in engagements for SoftNet in our core businesses, infrastructure and application development through a more efficient, timely and personalized approached to securing engagements. This will allow the Company to showcase and leverage two of our key reputation drivers; the quality of our consultants and recruiting capability,” said Jim Booth, President of SoftNet.

 

SUSPECT DETECTION SYSTEMS INCORPORATION (OTC: SDSS)

"Up 36.84% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SDSS.php 

 

Suspect Detection Systems Ltd. is a developer of proprietary anti-terror and anti-crime technology designed to identify threats in real-time, and prevent incidents before they are carried out. The technology detects the hidden 'hostile intent' of assailants-before they commit their intended acts-with a remarkable degree of accuracy. The system can also be used after crime was committed to quickly identify criminals from among a pool of suspects.

 

SDSS News:

 

September 1 - Suspect Detection Systems Inc. Signs 7-Digit (USD) Contract to Install Cogito System at a National Border Crossing

 

Suspect Detection Systems Inc. (OTCBB: SDSS), a leading developer of counter-terror and crime prevention technology, announced that a 7-digit contract has been signed with a Federal Agency in a major country to deploy the Cogito(TM) rapid interrogation system along a major national border.

 

Cogito will be used to interrogate potential suspects seeking entry into the country at a specific point of entry. Few Cogito units will be installed at the border crossing, along with the full installation of the Cogito Central Database and Management System (CDMS) which stores all data collected by each of the units.

 

The system is currently being customized to interrogate potential suspects in few languages. The CDMS control and manage all the Cogito units in real time and can analyze the biometric information and test result collected in the database.

 

"Our system was designed specifically to aid in the apprehension of terrorists and criminals at border crossings," said Shabtai Shoval, CEO of Suspect Detection Systems Ltd. "We have worked tirelessly to develop a comprehensive system that can accurately identify suspects at any time of day or night, without the aid of experienced interrogators. We are confident that Cogito will contribute to a safer, less porous border."

 

Cogito is an automated interrogation system that is used to accurately detect the hostile intent of suspected criminals and terrorists in just five to seven minutes. The system was designed under the concept that the most dangerous weapon a suspect will carry is his or her intent to commit a destructive act

 

Cogito can easily be deployed to detect terrorists, smugglers and criminals at checkpoints, border crossings, crime scenes, war zones, or in private enterprises.

 

"Cogito is a powerful tool that can be utilized by any organization with advanced security and crime prevention operations from private enterprises to federal agencies," added Shoval. "The positive feedback we have received from Cogito customers demonstrates the impact of the system on the war against crime."

 

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

 

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

 

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

 

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

 

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

 

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org.

 

Disclosure: OTCPicks.com has been compensated three thousand five hundred dollars from a third party (Longview Communications Corp.) for ACCP advertising and promotional services. OTCPicks.com is being compensated eight thousand dollars by a third party (Mickey Reno) for EWRC advertising and promotional services. OTCPicks.com has been compensated twenty thousand free trading shares by a non-controlling third party for GOHG advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by the company for GSAE advertising and promotional services. OTCPicks.com has recently been compensated five thousand free trading shares from Onyx Consulting for GSAE advertising and promotion. OTCPicks.com has been compensated nine thousand five hundred dollars by the company for CHYU advertising and promotional services. OTCPicks.com has been compensated three thousand dollars by a third party (Stock Awareness Group) for MRNJ advertising and promotional services. OTCPicks.com has been compensated three thousand dollars by a third party (Microcap Awareness) for a previous SNRY advertising and promotional campaign. Currently OTCPicks.com is being compensated two thousand five hundred dollars from BlueWave Advisors for SNRY advertising and promotional services. OTCPicks.com has been compensated two thousand five hundred dollars by a third party (Blue Wave Advisors) for SDSS advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.